Constantin Schwab

8PUBLICATIONS
87CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Contaminant hydrologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 09, 2026
Integrating NECTIN4 Amplification With Membranous Nectin-4 Expression to Develop a Scoring System for Predicting Enfortumab Vedotin Response in Urothelial Carcinoma.

|Apr 14, 2026
Evaluation of the Proliferation Marker Ki-67 for Improved Risk Stratification of Prostate Cancer Patients Under Active Surveillance.

Viktoria Schütz, Maresa Rothermel, Adam Kaczorowski

|Sep 05, 2025
Interdisciplinary evidence-based tumor board simulation training in surgical medical education.

Nora Corinna Altmayer, Elias Khajeh, Johanna Fellhofer-Hofer

|Apr 27, 2024
Clinical Relevance of Pathological Diagnosis of Hirschsprung's Disease with Acetylcholine-Esterase Histochemistry or Calretinin Immunohistochemistry.

Philipp Romero, Astrid Burger, Erica Wennberg

|Apr 24, 2024
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.

Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz

|Apr 13, 2024
PD-L1 as a Urine Biomarker in Renal Cell Carcinoma-A Case Series and Proof-of-Concept Study.

Philipp Reimold, Georgi Tosev, Adam Kaczorowski

Pageof 2

Frequent Collaborators

3 joint publications

Niklas Klümper

3 joint publications

Viktor Grünwald

3 joint publications

Manuel Ritter

3 joint publications

Steffen Rausch